A tyrosine kinase inhibitor (STI571, Gleevec) has recently been applied in the treatment of chronic myeloid leukemia. We present the first reported case of pityriasis rosea occurring as a reaction to Gleevec in a woman with blast crisis of this disorder. It is suggested that although coincidental, this exanthem may be due to this agent.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000063900 | DOI Listing |
Publication Analysis
Top Keywords
pityriasis rosea
8
sti571 gleevec
8
rosea associated
4
associated imatinib
4
imatinib sti571
4
gleevec tyrosine
4
tyrosine kinase
4
kinase inhibitor
4
inhibitor sti571
4
gleevec applied
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!